DC-CPin7

• UNSPSC Description:

  DC-CPin7 is a potent inhibitor of CREB-binding protein (CBP) bromodomain with an IC50 of 2.5 μM[1].

• Target Antigen:

  Epigenetic Reader Domain

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/dc-cpin7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC(C1C(CC=CC1)C(NC2=CC3=C(C=C2)N(C(OC)=O)CCC3)=O)=O

• Molecular Weight:

  358.39

• References & Citations:

  [1]Chen Y, et al. Design, synthesis, and biological evaluation of tetrahydroquinolin derivatives as potent inhibitors of CBP bromodomain. Bioorg Chem. 2020 Aug;101:103991.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  893781-17-4